Supplementary Table 5 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
Sandra M. Lopez(Johns Hopkins University), Irina U. Agoulnik(University of South Florida), Gregory A. Gandarillas(Florida International University), L. E. Peterson(Baylor College of Medicine), Rile Li(Baylor College of Medicine), Christian Coarfa(Baylor College of Medicine), Alexander I. Agoulnik(Florida International University), Nancy L. Weigel(Baylor College of Medicine), Michael Ittmann(Baylor College of Medicine), Egla Suarez(Florida International University), Anna Frolov(Baylor College of Medicine), Kimal Rajapakshe(Baylor College of Medicine), Manqi Zhang(Southwest University)
Cited by 0
Related Papers
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
Widespread deregulation of microRNA expression in human prostate cancer
|Oncogene|2007|635
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
Spectrum of CHD7 Mutations in 110 Individuals with CHARGE Syndrome and Genotype-Phenotype Correlation
|The American Journal of Human Genetics|2006|393
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390